Each year we reveal the best capital markets transactions and investment banks in Japan. We begin with M&A and equity awards, where Astellas made a contentious takeover of OSI, Dai-Ichi's IPO made a splash, and Inpex's follow-on generated strong demand.
Astellas Pharma’s US$4.078 billion acquisition of OSI Pharmaceuticals
Advisers to Astellas: Citi
Advisers to OSI: Bank of America-Merrill Lynch; Lazard; Centerview Partners
The quest of Japanese companies for growth beyond a stagnant domestic economy with a rapidly ageing population is driving a boom in Japan cross-border M&A. Many potential